Trials / Completed

CompletedNCT01714544

Study of the Efficacy of Cloderm® Cream in the Treatment of Moderate Plaque Psoriasis

An Open-Label, Multicenter Study of the Efficacy of Cloderm® Cream (Clocortolone Pivalate, 0.1%) in the Treatment of Moderate Plaque Psoriasis for 28 Days

Status: Completed
Phase: Phase 4
Study type: Interventional
Enrollment: 60 (actual)

Sponsor: Promius Pharma, LLC · Industry
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether Cloderm Cream is effective for topical treatment of moderate psoriasis over 28 days.

Detailed description

The objective of this study is to estimate the efficacy of Cloderm Cream for topical treatment of moderate plaque psoriasis over 28 days using current standards for evaluation.

Conditions

Psoriasis

Interventions

Type	Name	Description
DRUG	Cloderm Cream

Timeline

Start date: 2012-10-01
Primary completion: 2013-03-01
First posted: 2012-10-26
Last updated: 2014-07-23
Results posted: 2014-07-23

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01714544. Inclusion in this directory is not an endorsement.